SureTrader SPDR Advertisement SPDR Advertisement
Home > Boards > US OTC > Medical - Healthcare >

Endocan Corp. (ENDO)

Add ENDO Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator sicofbs, Doc K
Search This Board:
Last Post: 3/3/2015 11:45:56 PM - Followers: 181 - Board type: Free - Posts Today: 0

About Endocan Corporation

The brand name Endocan(TM) was chosen by the Board as a direct reference to the endocannabinoid system of the human body. The endocannabinoid system is a group of neuromodulatory compounds and their receptors that are involved in a variety of fundamental physiological processes including pain-sensation, immune function, stress, sleep, mood, appetite, and memory. Cannabinoids from plants, including those found in the Cannabis genus, as well as those autonomously produced within living biological systems, work together in the operation of the endocannabinoid system. The modulation of this system is the basis for cannabinoid-based medical treatments to assist patients to improve their health and well-being.

Premium quality of life is one of the most rewarding ways to feel great and outright spoil ourselves. The Endocan product line by The Endocan Corporation is a new stage of
innovative cannabinoid-based solutions, with a fresh focus on the health decisions of today. The critical ailments, such as cancer,AIDS/HIV, asthma, glaucoma, influenza,
pain management, & PTSD to more general conditions, such as sunburn and skin dryness, all seem to have a beneficial response to cannabinoids.
Endocan utilizes the unique and potent benefits of cannabinoids; the natural components found in the cannabis plant.
Cannabinoids are the ideal solution due to their organic properties that the body responds extremely well to. Endogenous endocannabinoid system is responsible for
the unique communication pathways in the brain and body affecting many important functions including modulation of the response to disease. Our formulations
target the endocannabinoid system thus affecting the cause, not only the symptoms. Endocan’s motivation to bring superior products to their respective markets is based on the incredible market need for answers to critical ailments and generalconditions.
The personal care market including   cosmeceuticals, nutraceuticals, and anti-aging is one of the largest in the world.


Endocan Corporation, (FKA The X-Change Corporation) is currently developing new natural cannabinoid containing products based on innovative formulations to utilize the unique and potent benefits of the cannabis and hemp plants. Medicinal properties of cannabis, and hemp have been known and applied for thousands of years. With the aid of scientific research, Endocan Corporation is translating such knowledge into development of effective cannabinoid formulation-based health and wellness solutions as well as cosmeceutical, nutraceutical, and food brands throughout the world. The Company's health and wellness, nutritional, and cosmetics lines will address personal needs and will evolve with the introduction of new formulations and products, advancing the Company within the expanding multibillion-dollar global market.





Corporate Overview

"GOOD HEALTH! In an ever changing world the one thing that should be maintained is good health."

Endocan is the next stage of innovative cannabinoid-based solutions, with a focus on the health needs of people today. Globally, the diagnoses of critical ailments such as HIV/AIDS, cancer, autoimmune disease, high blood pressure, dementia, and more are arising. Despite scientific advances, we are facing a situation in which millions of people continue to be affected by life-threatening conditions with no truly effective means of treating them. The world needs smart science and research, strong leadership, and new products to respond to ever growing medical need.

Endocan utilizes the unique and potent benefits of cannabinoids, the natural compounds found in the Cannabis plants, from which cannabis and hemp are produced. Cannabinoid based products are potentially the ideal solution for many conditions and diseases.

Endocan strives to become known as one of the quintessential brands in the world, featuring multiple products, including cosmeceuticals and nutraceuticals. Cosmetics and nutrition are personal over the counter markets that continuously evolve with new formulations and products. The personal care market is estimated at $350 billion in 2012, with skin care growing approximately 7% over the next five years. The U.S. cosmeceuticals market is estimated at about $5-6 billion, while in the EU the market is worth between $3 and $5 billion. The Japanese is a market worth of about $6-8 billion.

Endocan, we believe, will capture a sizable portion of the market as Endocan becomes a household name. Endocan is poised to become known and flourish in the retail marketplace.

Endocan has something unique to offer with our formulation and innovative products and branding identity. Our formulations include natural, proprietary oil extracts to ensure the quality and effectiveness of the products.

Sales for Endocan's product lines are forecasted to grow into hundreds of millions of dollars upon realization of full global expansion and franchising opportunities.

Endocan is poised to flourish in the retailmarket place. Endocan aims to capture a profitable share of the personal care as well as a portion of the critical ailment markets.Endocan diversifies it product base into more product lines and marketing focuses on Endocan becoming more of a household name.
Endocan’s unique formulations matched with Endocan’s unmatched ability to deliver new and exciting products to the market
enhanced by our branding identity is essential to our success. Our formulations include proprietary extracts
that increase the quality, durability, and effectiveness of the products, especially when compared to other consumer options that currently exist on the shelf.
Sales are illustrated to rise to over $100million dollars over five to ten years as the
company benefits from both global expansion and franchising opportunities.



           About Cannabis & Cannabinoids

About CannabiinoidsThere are over 525 natural components found in the Cannabis plant. Cannabinoids are believed to be at least 85 if not over 100 of these natural components. These components interact with specific receptors called “cannabinoid receptors.”

Two receptors have been found to date, called CB1 and CB2. The cannabinoids are separated into subclasses:


  • Cannabigerols (CBG)
  • Cannabichromenes (CBC)
  • Cannabidiols (CBD)
  • Tetrahydrocannabinols (THC)
  • Cannabinol (CBN) and Cannabinodial (CBDL)
  • Other Cannabinoids

The cannabinoids mentioned most often are Tetrahydrocannabinols (THC) and Cannabidiols, for the simple reason that they are more frequently occurring in most strains and produce the most activity in the body. A substance that occurs naturally in the brain and binds to CB1 receptors was discovered in 1992 by Raphael Mechoulam’s team at the Hebrew University in Jerusalem. This substance is called “anandamide.” Other naturally occurring substances that bind to CB1 have been discovered since then. Together, they are called the “endogenous cannabinoid system” or the “endocannabinoid system.”


The cannabinoids most useful in combatting the world’s devastating illnesses are THC (delta-9 tetrahydrocannabinol) and CBD (cannabidiol), though other cannabinoids are beneficial as well. Major ailments, such as squamous and basal cell carcinomas, respond very positively to the topical application of oil extracted from the cannabis plant and containing high concentrations of THC. More about this process can be seen in our Patient Resource Center.


A major ingredient in our skincare products is hemp, which is a distant cousin to cannabis. Its main ingredient is the non-psychoactive cannabinoid called cannabidiol or CBD. Industrial hemp is characterized as being low in THC (delta-9 tetrahydrocannabinol) and high in CBD. CBD’s anti-cancer potential is currently being studied actively. It also has been shown to suppress inflammatory and neuropathic pain, exert anti-convulsant effects, and control other types of chronic pain, according to the National Center for Biotechnology Information. While CBD is important in treating certain ailments, the skin benefits most from the Omega-3 and Omega-6 essential fatty acids that are found in hemp.

History of Cannabis

The use of cannabis is thought to stretch back 4,000 years. It has been used as a medicine globally, including India, China, and the Middle East. In China, it was used to treat malaria, constipation, and rheumatism. There are even theories that cannabis use appears in the Old Testament of the Bible.

In the middle of the nineteenth century, doctors began to take an interest in it as a medicine, and it was a popular choice. Even Queen Victoria of England was given cannabis by her doctor to relieve period pains. Beginning in the early 20th century, cannabis began to be made illegal around the world, including North America and Europe.

The recreational use of cannabis has continued through today, and scientists and doctors have started studying the medicinal benefits of the plant as well. The first country to federally legalize cannabis for medicinal use was Canada in 2000. The first state in the U.S. was California in 1996. Twenty states and the District of Columbia have legalized medical cannabis in the United States and additional states are considering doing so as well.





Critical Ailments

Endocan develops products for critical ailments.

The number of diagnoses for various life-threatening diseases is rising every day. Endocan recognizes this global pandemic and is committed to with smart and sensible science.

Endocan's product lines continue to mature toward critical care for people suffering from life threatening diseases like cancer and HIV. The Company's strategic research collaborations, including our strategic partners, Cannabis Science, Inc. and the medical cannabis dispensaries in legal state jurisdictions, will advance these cannabinoid-based breakthroughs in the rapidly expanding critical care market. Further, while chemotherapy and surgical treatment costs quickly rise into the hundreds of thousands of dollars per patient on an annual basis, safe, natural, and effective cannabinoid-based treatments for the same ailments are projected to cost less than ten thousand dollars per patient per annum.

Diagnoses of certain maladies are rising, and more diseases are constantly added to the medical canon. Many diseases have been classified as epidemics. The people on this planet are in dire need of something new. Endocan has identified 20 critical ailments that cannabinoids can treat and numerous skin afflictions as well. This section covers the 5 Why's and 1 How about these ailments:

Who can get them? What are they? When can a patient contract them? Where in the body do they appear, and what are the symptoms? Why do they show up? And lastly: How can cannabinoids make a difference?

Explore this section for this information, whether you are a patient, have a loved one with an illness, or are merely interested in cannabinoid science.


Table: Market Analysis


Market Analysis Chart


Table: Global Potential Customers

Global Potential Customers Chart

Table: Global Potential Customers - Cancer

Global Potential Customers with Cancer Chart





Corporate Profile

Endocan is dedicated to quality, respect for human life, and constant evaluation.

Respect for human life is a core value at Endocan. We believe that there are countless possibilities to be unleashed from the cornucopia of nature for good health and wellbeing. We use the latest science and technology to study these possibilities and make our products accessible to all. First, all Europe, the United States, and beyond.

Our employees are a central part of the company as well. We always take their needs into consideration. They are trained to comply with all laws and mandates. Our employees are held to high standards and rewarded for their work.


Executive Summary

Please click on the document title to download.

Download PDF Document Endocan Corporation 2013 Executive Summary

Endocan Moves Forward With New Product Releases After Successful Brand and Website Launch; Focused Efforts Include Product Distribution Outlets for USA, Canada, and Europe Oct-23-2013
Endocan Corporation (XCHC) is Pleased to Announce the Endocan™ Website Goes Live Today Oct-17-2013
Endocan Corporation XCHC Excited to Announce Launch of New Website and Corporate Brand Endocan™ on Thursday, October 17, 2013 to Further Advance Industry-Driven Branding to Bring its Medical Cannabis Formulations to Market as its Next Major Corporate Move Oct-14-2013
Endocan Corporation, FKA The X-Change Corp, Motivated by Canadian Government Move; From Huffington Post: 'Canada Medical Marijuana: Health Canada Presides Over Birth Of Billion-Dollar Free Market' Oct-01-2013
XCHC Changes Corporate Name to "Endocan Corporation"; Medical Cannabis Industry-Driven Branding Campaign Begins with Name Change and Continues into the Arizona Dispensary Opening Sep-26-2013
The X-Change Corporation To Announce Corporate Name Change Next Week; New Industry-Driven Branding to Commence For Global Activities, Services, Product Lines, and Website Sep-06-2013
X-Change Corp. Recaps Significant Corporate Activities for Past 15 Days Sep-05-2013
X-Change Corp. Delighted with DOJ's Historic Shift Toward Non-Interference Within State Cannabis Regulatory Environments; Sees 'Green Light' for Company's Patient-Driven Medical Cannabis Operations Under State Laws Aug-30-2013
X-Change Moves Forward Signing Next Multi-Year Contracts with State-Licensed Medical Cannabis Dispensary in Arizona to Develop, Dispense, Infuse, and Cultivate Products for On-Site, Use of 'Medbox' Technology for Fulfillment, and Distribution Aug-21-2013
X-Change Corporation Signs Multi-Million Dollar Agreement for Multi-State Product Release Licensing, Medical Cannabis Dispensary Management, and Cultivation Consulting Aug-20-2013

Management Team

Dr Dorothy Bray, Ph.D.
Director & President
Chad S. Johnson, Esq.
Director, COO &General Counsel
Mario Lap
Director & President of European Operations
Robert Kane
Director, CFO & Sr.VP for Business Development
Alfredo Dupetit
Director & VP European Operations
Drue Young
Vice President of Product Development

Steven B. Hopping, M.D., F.A.C.S.

Board of Advisors, Senior Medical Advisor
Greta Gaines

Board of Advisors, Marketing Specialist
Greta Gaines


Company Stock Symbol
XCHC - View Stock Quote

Share Structure
Common Stock
Authorized - 750,000,000
Issued - 26,746,504
Par Value - $0.001

Preferred Stock
Authorized - 100,000,000
Issued - NIL
Par Value - $0.001

Stock Transfer Agent
Signature Stock Transfer, Inc.
2632 Coachlight Court
Plano, TX 75093
Phone: (972) 612-4120



  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ENDO News: Initial Statement of Beneficial Ownership (3) 02/11/2015 02:43:00 PM
#8496   New ID created and under 5 postings???? anon13333 03/03/15 11:45:56 PM
#8495   Dabney states that associated companies are only days Edgegetter 03/03/15 04:26:56 PM
#8494   I hear you loud n clear... Thanks for twicemillion 02/28/15 05:06:06 AM
#8493   Don't say no one tried to warn Doc K 02/27/15 11:46:18 PM
#8492   How can you have faith in a Doc K 02/27/15 11:44:29 PM
#8491   Seriously? Why would you get in Doc K 02/27/15 11:42:46 PM
#8490   Thanks for the input... Penny stock is risky twicemillion 02/27/15 09:45:32 PM
#8489   Along with just about every ticker in the sector. oystersnbeer 02/27/15 04:05:17 PM
#8488   Got into this today. Looks oversold to me 2434nate 02/27/15 01:28:08 PM
#8487   Perhaps you should do a little dd on sicofbs 02/27/15 12:55:22 PM
#8486   Let the dumparoo commence!! BagHolder777 02/27/15 12:47:28 PM
#8485   Anyone here still have faith in this company? twicemillion 02/27/15 12:46:12 PM
#8484   Yes it is Chad Johnson and Dorothy bry sicofbs 02/25/15 09:01:39 PM
#8483   What a joke. lol This is heading to 0.0001. Heinekenken 02/25/15 02:00:00 PM
#8482   Let's hope once Texas legalizes marijuana this company Twincity87 02/23/15 12:21:49 PM
#8481   Well, I think they will annouce to change Heinekenken 02/17/15 04:46:24 PM
#8480   Melamede Cowan Dabney Kane bray Johnson have all sicofbs 02/15/15 06:33:56 PM
#8479   Looks like this hada good day. bensondog 02/13/15 10:32:24 PM
#8477   Time for another ENDO dumparoo BagHolder777 02/11/15 03:02:02 PM
#8476   Looks like bray and Johnson are really bad sicofbs 02/10/15 09:34:56 AM
#8475   RE: It looks like Johnson and Dabney are Heinekenken 02/09/15 12:29:31 PM
#8474   It looks like Johnson and Dabney are teamed sicofbs 02/09/15 11:29:59 AM
#8473   Ohhhhh, it means that Kane found the cheap Heinekenken 02/09/15 03:19:25 AM
#8469   Endocan Provides Shareholder Guidance for its Medicine Dispensing sicofbs 02/02/15 01:34:46 PM
#8467   Yeah Robert ? C'mon I tried Vmax1 01/30/15 05:07:40 PM
#8466   I'm surprised this isn't halted yet. When Doc K 01/29/15 03:38:04 PM
#8465   Has anyone had contact with Kane Dabney Johnson sicofbs 01/29/15 03:36:22 PM
#8464   Now Raymond...were you lying to dump Cbis stock sicofbs 01/26/15 12:17:02 PM
#8463 you really sell 104 shares...c'mone now, cool sicofbs 01/22/15 10:36:10 AM
#8462   So Dabney ,you and Kane started this company sicofbs 01/21/15 01:36:44 PM
#8460   I think we debated whether Kane was a sicofbs 01/08/15 11:26:19 PM
#8459   I can't believe this POS empty shell of Doc K 01/08/15 09:59:26 PM
#8458   Robert ? WTF ? Vmax1 01/08/15 08:36:47 PM
#8457   Well at least share the 8 products so sicofbs 01/06/15 09:32:59 AM
#8456   Hey bray...on 7/10/13 you said you were ready sicofbs 01/04/15 03:09:22 PM
#8455   Hey Dorothy ...I want our products back from sicofbs 01/02/15 10:47:04 AM
#8454   Really $18.00 dollar trade Dabney....lmao...worlds foremost authority sicofbs 12/31/14 09:57:49 AM
#8453   Looks like Johnson and dabney are dumping like sicofbs 12/29/14 06:18:15 PM
#8451   Looks like the Dabney dump is getting serious sicofbs 12/24/14 12:39:18 PM
#8450   Pretty amazing what Dabney and Kane have dome sicofbs 12/23/14 08:28:37 PM
#8449   Nothing and this will be almost decade to Heinekenken 12/23/14 03:28:52 PM
#8448   Dabney ran his first Cbis product story sicofbs 12/19/14 10:21:05 AM
#8447   I think Dabney should photo himself in front sicofbs 12/18/14 11:16:44 AM
#8446   There are so many issues with this and sicofbs 12/17/14 11:13:42 AM
#8442   Coincidentally, today, I thought the same whether this Heinekenken 12/09/14 01:12:33 PM
#8441   If this gets halted the house of cards sicofbs 12/09/14 11:15:14 AM
#8440   They haven't haulted this pos yet? Doc K 12/09/14 10:39:16 AM
#8439   I'm guessing the products Dabney says he has sicofbs 12/08/14 07:21:50 PM
#8436   Have faith...I'm sure they are ready to announce sicofbs 11/27/14 12:57:08 PM
#8434   END and OVER Not gonna happen, that's Heinekenken 11/26/14 04:24:45 PM